AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
Latest, FY2025
4,951
Period ended Dec 31, 2025
Change on a year earlier
+18.4%
4,181 in FY2024
History
14 years
Since FY2012
Sources
14
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Inventories ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4,951 | +18.4% | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 4,181 | +2.0% | Form 10-K (filed 2025-02-14) ↗ |
| FY2023 | Dec 31, 2023 | 4,099 | +14.5% | Form 10-K (filed 2024-02-20) ↗ |
| FY2022 | Dec 31, 2022 | 3,579 | +14.4% | Form 10-K (filed 2023-02-17) ↗ |
| FY2021 | Dec 31, 2021 | 3,128 | -5.5% | Form 10-K (filed 2022-02-18) ↗ |
| FY2020 | Dec 31, 2020 | 3,310 | +82.6% | Form 10-K (filed 2021-02-19) ↗ |
| FY2019 | Dec 31, 2019 | 1,813 | +13.0% | Form 10-K (filed 2020-02-21) ↗ |
| FY2018 | Dec 31, 2018 | 1,605 | 0.0% | Form 10-K (filed 2019-02-27) ↗ |
| FY2017 | Dec 31, 2017 | 1,605 | +11.1% | Form 10-K (filed 2018-02-16) ↗ |
| FY2016 | Dec 31, 2016 | 1,444 | -16.0% | Form 10-K (filed 2017-02-17) ↗ |
| FY2015 | Dec 31, 2015 | 1,719 | +52.9% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 1,124 | -2.3% | Form 10-K (filed 2015-02-20) ↗ |
| FY2013 | Dec 31, 2013 | 1,150 | +5.4% | Form 10-K (filed 2014-02-21) ↗ |
| FY2012 | Dec 31, 2012 | 1,091 | – | Form 10-Q (filed 2013-05-08) ↗ |
Cite this data
StockData. (2026). AbbVie Inventories ($M) ($M), annual FY2012–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/fs_inv
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.